Achilles Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ACHL and buy or sell other stocks, ETFs, and their options commission-free!About ACHL
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens.
CEOIraj Ali, PhD
CEOIraj Ali, PhD
Employees—
Employees—
HeadquartersAltrincham, Cheshire East
HeadquartersAltrincham, Cheshire East
Founded2016
Founded2016
Employees—
Employees—
ACHL Key Statistics
Market cap60.83M
Market cap60.83M
Price-Earnings ratio-0.89
Price-Earnings ratio-0.89
Dividend yield—
Dividend yield—
Average volume934.64K
Average volume934.64K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.51
52 Week high$1.51
52 Week low$0.63
52 Week low$0.63
Stock Snapshot
Achilles Therapeutics(ACHL) stock is priced at $1.48, giving the company a market capitalization of 60.83M. It carries a P/E multiple of -0.89.
On 2025-12-14, Achilles Therapeutics(ACHL) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 934.64K.
The stock's 52-week range extends from a low of $0.63 to a high of $1.51.
The stock's 52-week range extends from a low of $0.63 to a high of $1.51.